Foghorn Cash Flow To Debt Ratio from 2010 to 2024
| FHTX Stock | USD 6.11 0.25 4.27% |
Cash Flow To Debt Ratio | First Reported 2010-12-31 | Previous Quarter (2.62) | Current Value (2.49) | Quarterly Volatility 1.89900514 |
Check Foghorn TherapeuticsInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Foghorn main balance sheet or income statement drivers, such as Net Interest Income of 11.1 M, Interest Income of 11.1 M or Depreciation And Amortization of 9.1 M, as well as many exotic indicators such as Price To Sales Ratio of 7.53, Dividend Yield of 0.0 or Days Sales Outstanding of 66.4 K. Foghorn financial statements analysis is a perfect complement when working with Foghorn TherapeuticsInc Valuation or Volatility modules.
Foghorn | Cash Flow To Debt Ratio |
Latest Foghorn TherapeuticsInc's Cash Flow To Debt Ratio Growth Pattern
Below is the plot of the Cash Flow To Debt Ratio of Foghorn TherapeuticsInc over the last few years. It is Foghorn TherapeuticsInc's Cash Flow To Debt Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Foghorn TherapeuticsInc's overall financial position and show how it may be relating to other accounts over time.
| Cash Flow To Debt Ratio | 10 Years Trend |
|
Cash Flow To Debt Ratio |
| Timeline |
Foghorn Cash Flow To Debt Ratio Regression Statistics
| Arithmetic Mean | (2.29) | |
| Geometric Mean | 2.48 | |
| Coefficient Of Variation | (82.85) | |
| Mean Deviation | 1.25 | |
| Median | (3.22) | |
| Standard Deviation | 1.90 | |
| Sample Variance | 3.61 | |
| Range | 6.981 | |
| R-Value | 0.53 | |
| Mean Square Error | 2.81 | |
| R-Squared | 0.28 | |
| Significance | 0.04 | |
| Slope | 0.22 | |
| Total Sum of Squares | 50.49 |
Foghorn Cash Flow To Debt Ratio History
About Foghorn TherapeuticsInc Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Foghorn TherapeuticsInc income statement, its balance sheet, and the statement of cash flows. Foghorn TherapeuticsInc investors use historical funamental indicators, such as Foghorn TherapeuticsInc's Cash Flow To Debt Ratio, to determine how well the company is positioned to perform in the future. Although Foghorn TherapeuticsInc investors may use each financial statement separately, they are all related. The changes in Foghorn TherapeuticsInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Foghorn TherapeuticsInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Foghorn TherapeuticsInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Foghorn TherapeuticsInc. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Cash Flow To Debt Ratio | (2.62) | (2.49) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Foghorn TherapeuticsInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Foghorn TherapeuticsInc's short interest history, or implied volatility extrapolated from Foghorn TherapeuticsInc options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Foghorn TherapeuticsInc Correlation against competitors. For more information on how to buy Foghorn Stock please use our How to Invest in Foghorn TherapeuticsInc guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Foghorn Stock analysis
When running Foghorn TherapeuticsInc's price analysis, check to measure Foghorn TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foghorn TherapeuticsInc is operating at the current time. Most of Foghorn TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Foghorn TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foghorn TherapeuticsInc's price. Additionally, you may evaluate how the addition of Foghorn TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format |
Is Foghorn TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Foghorn TherapeuticsInc. If investors know Foghorn will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Foghorn TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.34) | Revenue Per Share 0.814 | Quarterly Revenue Growth 0.379 | Return On Assets (0.20) | Return On Equity (4.70) |
The market value of Foghorn TherapeuticsInc is measured differently than its book value, which is the value of Foghorn that is recorded on the company's balance sheet. Investors also form their own opinion of Foghorn TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Foghorn TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Foghorn TherapeuticsInc's market value can be influenced by many factors that don't directly affect Foghorn TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Foghorn TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Foghorn TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Foghorn TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.